Berlin SME developing polymer-composite surgical gloves that protect healthcare workers from needlestick injuries and surgical site infections.
Smarterials Technology is a Berlin-based materials science SME that develops advanced protective gloves for healthcare workers using polymer-particle composite technology. Their core innovation is engineering composite materials that resist needle penetration while preserving the dexterity surgeons and clinical staff need — directly targeting the needlestick injury problem that affects millions of healthcare workers annually. They followed a disciplined EU SME Instrument path: first validating the concept with a feasibility study (Composite Gloves, 2018), then securing major Phase 2 funding to bring the SafeGlov product to market (2019–2023). Their work spans advanced materials formulation, medical device manufacturing, and infection prevention — placing them at a commercially sharp intersection of materials science and healthcare safety.
Both Composite Gloves and SafeGlov are built around polymer-particle composite engineering, with SafeGlov explicitly listed under 'polymer-particle composites' and 'advanced materials' keywords.
The SafeGlov project (EUR 1,850,060) is specifically titled 'Safety Gloves for Protection of Health Care Professionals' and lists 'needlestick injuries' and 'double gloving' as core keywords.
Both projects address clinical glove manufacturing, with 'manufacturing and processing' and 'surgery' listed among SafeGlov's keywords, indicating hands-on production capability alongside material design.
SafeGlov's keyword set includes 'infection prevention' and 'surgical site infections', showing that the product scope extends beyond physical puncture protection to broader clinical safety outcomes.
Smarterials followed a tightly focused, linear development path rather than diversifying across topics. Their earliest project (Composite Gloves, 2018–2019) was a lean feasibility exercise with no detailed keywords recorded, suggesting it was primarily a proof-of-concept and market validation stage. By the time SafeGlov launched in 2019, their keyword profile had fully crystallized around a coherent cluster: needlestick injury prevention, polymer-particle composites, double gloving, surgical site infections, and manufacturing — indicating that Phase 2 represented a mature, well-defined product rather than an exploratory pivot. There is no thematic drift in their trajectory; instead, what looks like evolution is actually deepening: they moved from a materials idea to a fully specified medical device with clinical safety positioning.
Smarterials is on a commercialization trajectory — having successfully completed the full SME Instrument Phase 1 → Phase 2 arc, they are likely seeking manufacturing scale-up partnerships, CE marking support, or hospital procurement channels rather than additional research funding.
Smarterials has coordinated both of their H2020 projects independently, with no recorded consortium partners — a pattern typical of SME Instrument recipients who are product companies rather than research consortia builders. This means they operate as entrepreneurial technology developers who drive the agenda and own the IP, rather than slotting into larger multi-partner structures. For potential collaborators, this suggests they are best engaged as a technology supplier or co-development partner on their specific glove technology, not as a consortium hub that brings in diverse sub-contractors.
Smarterials has no recorded consortium partners across their two H2020 projects, which is consistent with the solo-applicant model of the SME Instrument funding scheme. Their network footprint in EU project databases is narrow, but this does not preclude strong industry relationships outside the formal consortium structure.
Smarterials occupies a very specific niche: they are not a general PPE manufacturer but a materials-science-first company that engineered composite polymer technology specifically for surgical-grade needlestick protection — a problem that standard latex or nitrile gloves do not adequately solve. Having completed the full SME Instrument cycle (Phase 1 + Phase 2) with nearly EUR 1.9M in EU validation, they carry proof of technical and commercial credibility that few single-product medical device SMEs can claim at this scale. For a consortium looking for a specialist in protective composite materials or a healthcare system seeking a validated needlestick prevention solution, Smarterials brings a finished-product asset rather than early-stage research.
